Linked Life Data

11331396

Source:http://linkedlifedata.com/resource/pubmed/id/11331396

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11331396rdf:typepubmed:Citationlld:pubmed
pubmed-article:11331396lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:11331396lifeskim:mentionsumls-concept:C0521329lld:lifeskim
pubmed-article:11331396lifeskim:mentionsumls-concept:C1309732lld:lifeskim
pubmed-article:11331396lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:11331396lifeskim:mentionsumls-concept:C0018282lld:lifeskim
pubmed-article:11331396lifeskim:mentionsumls-concept:C2004454lld:lifeskim
pubmed-article:11331396lifeskim:mentionsumls-concept:C1753129lld:lifeskim
pubmed-article:11331396lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:11331396pubmed:issue10lld:pubmed
pubmed-article:11331396pubmed:dateCreated2001-5-24lld:pubmed
pubmed-article:11331396pubmed:abstractTextThe limited plastic and regenerative capabilities of axons in the adult mammalian CNS can be enhanced by the application of a monoclonal antibody (mAb), IN-1, raised against the myelin-associated neurite growth inhibitor Nogo-A. The aim of the present study was to investigate the effects of this treatment on the functional recovery of adult rats with a dorsal over-hemisection of the spinal cord. Directly after injury, half of the animals were implanted with mAb IN-1-secreting hybridoma cells, whereas the others received cells secreting a control antibody (anti-HRP). A broad spectrum of locomotor tests (open field locomotor) score, grid walk, misstep withdrawal response, narrow-beam crossing) was used to characterize locomotor recovery during the 5 weeks after the injury. In all behavioral tests, the recovery in the mAb IN-1-treated group was significantly augmented compared with the control antibody-treated rats. EMG recordings of flexor and extensor muscles during treadmill walking confirmed the improvement of the locomotor pattern in the mAb IN-1-treated rats; step-cycle duration, rhythmicity, and coupling of the hindlimbs were significantly improved. No differences between the two groups with regard to nociception were observed in the tail flick test 5 weeks after the operation. These results indicating improved functional recovery suggest that the increased plastic and regenerative capabilities of the CNS after Nogo-A neutralization result in a functionally meaningful rewiring of the motor systems.lld:pubmed
pubmed-article:11331396pubmed:languageenglld:pubmed
pubmed-article:11331396pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11331396pubmed:citationSubsetIMlld:pubmed
pubmed-article:11331396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11331396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11331396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11331396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11331396pubmed:statusMEDLINElld:pubmed
pubmed-article:11331396pubmed:monthMaylld:pubmed
pubmed-article:11331396pubmed:issn1529-2401lld:pubmed
pubmed-article:11331396pubmed:authorpubmed-author:DietzVVlld:pubmed
pubmed-article:11331396pubmed:authorpubmed-author:SchwabM EMElld:pubmed
pubmed-article:11331396pubmed:authorpubmed-author:FouadKKlld:pubmed
pubmed-article:11331396pubmed:authorpubmed-author:MerklerDDlld:pubmed
pubmed-article:11331396pubmed:authorpubmed-author:MetzG AGAlld:pubmed
pubmed-article:11331396pubmed:authorpubmed-author:RaineteauOOlld:pubmed
pubmed-article:11331396pubmed:issnTypeElectroniclld:pubmed
pubmed-article:11331396pubmed:day15lld:pubmed
pubmed-article:11331396pubmed:volume21lld:pubmed
pubmed-article:11331396pubmed:ownerNLMlld:pubmed
pubmed-article:11331396pubmed:authorsCompleteYlld:pubmed
pubmed-article:11331396pubmed:pagination3665-73lld:pubmed
pubmed-article:11331396pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11331396pubmed:meshHeadingpubmed-meshheading:11331396...lld:pubmed
pubmed-article:11331396pubmed:meshHeadingpubmed-meshheading:11331396...lld:pubmed
pubmed-article:11331396pubmed:meshHeadingpubmed-meshheading:11331396...lld:pubmed
pubmed-article:11331396pubmed:meshHeadingpubmed-meshheading:11331396...lld:pubmed
pubmed-article:11331396pubmed:meshHeadingpubmed-meshheading:11331396...lld:pubmed
pubmed-article:11331396pubmed:meshHeadingpubmed-meshheading:11331396...lld:pubmed
pubmed-article:11331396pubmed:meshHeadingpubmed-meshheading:11331396...lld:pubmed
pubmed-article:11331396pubmed:meshHeadingpubmed-meshheading:11331396...lld:pubmed
pubmed-article:11331396pubmed:meshHeadingpubmed-meshheading:11331396...lld:pubmed
pubmed-article:11331396pubmed:meshHeadingpubmed-meshheading:11331396...lld:pubmed
pubmed-article:11331396pubmed:meshHeadingpubmed-meshheading:11331396...lld:pubmed
pubmed-article:11331396pubmed:meshHeadingpubmed-meshheading:11331396...lld:pubmed
pubmed-article:11331396pubmed:meshHeadingpubmed-meshheading:11331396...lld:pubmed
pubmed-article:11331396pubmed:meshHeadingpubmed-meshheading:11331396...lld:pubmed
pubmed-article:11331396pubmed:meshHeadingpubmed-meshheading:11331396...lld:pubmed
pubmed-article:11331396pubmed:meshHeadingpubmed-meshheading:11331396...lld:pubmed
pubmed-article:11331396pubmed:meshHeadingpubmed-meshheading:11331396...lld:pubmed
pubmed-article:11331396pubmed:meshHeadingpubmed-meshheading:11331396...lld:pubmed
pubmed-article:11331396pubmed:meshHeadingpubmed-meshheading:11331396...lld:pubmed
pubmed-article:11331396pubmed:year2001lld:pubmed
pubmed-article:11331396pubmed:articleTitleLocomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A.lld:pubmed
pubmed-article:11331396pubmed:affiliationDepartment of Neuromorphology, Brain Research Institute, University and Swiss Federal Institute of Technology Zürich, 8057 Zürich, Switzerland.lld:pubmed
pubmed-article:11331396pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11331396pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11331396lld:pubmed